Niketa Shah, MD, Pediatric Hematology & Oncology, New Haven, CT, Yale-New Haven Hospital

NiketaCShahMD

Pediatric Hematology & Oncology New Haven, CT

Pediatric Stem Cell Transplant and Cellular Therapy Physician Yale School of Medicine

Dr. Shah is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Shah's full profile

Already have an account?

Education & Training

  • Memorial Sloan-Kettering Cancer Center
    Memorial Sloan-Kettering Cancer CenterFellowship, Pediatric Stem Cell Transplant, 2009 - 2010
  • Newark Beth Israel Medical Center
    Newark Beth Israel Medical CenterResidency, Pediatrics, 2006 - 2009
  • Hospital for Sick ChildrenPediatric Hematology Oncology Fellowship, 2003 - 2006
  • Gujarat Cancer and Research InstitutePediatric Hematology Oncology, 1997 - 2003
  • Sheth KM School of Post Graduate Medicine and ResearchMD, Pediatric Residency , 1994 - 1997
  • N.H.L Municipal Medical College
    N.H.L Municipal Medical CollegeClass of 1994

Certifications & Licensure

  • CT State Medical License
    CT State Medical License 2016 - 2022
  • AZ State Medical License
    AZ State Medical License 2010 - 2017
  • WI State Medical License
    WI State Medical License 2008 - 2009
  • American Board of Pediatrics Pediatrics
  • American Board of Pediatrics Pediatric Hematology-Oncology

Publications & Presentations

PubMed

Abstracts/Posters

  • Granulocyte Colony-Stimulating Factor Is Safe and Well Tolerated Following Allogeneic Transplantation in Patients with Sickle Cell Disease
    Niketa C. Shah, MD , Sweta Bhoopatiraju , Allistair Abraham, MD , Eric Jon Anderson, MD , Martin Andreansky, MD , Monica Bhatia, MD , Sonali Chaudhury, MD , Geoff D.E...., American Society of Hematology, Virtual, 12/5/2020
  • Allogeneic CD34-Selected HSCT Following CAR T-Cells Is Associated with Low TRM and Favorable OS in Pediatric/Young Adult Patients with Relapsed/Refractory B-ALL
    Niketa C. Shah, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Abatacept Is Effective for Gvhd Prophylaxis after Unrelated Donor Stem Cell Transplantation (URD SCT) for Severe Sickle Cell Disease (SCD)
    Niketa C. Shah, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Professional Memberships

Other Languages

  • Hindi, Gujarati

Hospital Affiliations